Framework Agreement for the Purchase of Spinraza® (nusinersen)

The purpose of this framework agreement is to supply the hospital pharmacies of Amgros' stakeholders with the medicinal product Spinraza® (nusinersen). Additionally, the Capital Region's hospital pharmacy will procure the drug for resale to Greenland and the Faroe Islands. Spinraza® is a crucial medication used in the treatment of certain rare neurological conditions. This framework agreement aims to establish a streamlined procurement process, ensuring reliable access to this important drug for patients across the involved regions. It will define the terms and conditions for the purchase, including pricing, delivery schedules, and quality standards, over a specified period. The agreement facilitates efficient supply chain management for a high-value pharmaceutical product, supporting healthcare providers in delivering necessary treatments.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Denmark, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.